Publicacións (219) Publicacións nas que participase algún/ha investigador/a

filter_list

2025

  1. Discovery of N-substituted-2-((arylethyl)amino)-2-(2-methoxyphenyl) acetamides: A novel family of antiplatelet agents

    Biomedicine and Pharmacotherapy, Vol. 186

  2. Shaping Future Medicinal Chemists: Perspectives from European Schools of Pharmacy within the GP2A Network

    Journal of Medicinal Chemistry

2024

  1. Benzylhydroxamic acids as inhibitors of insulin regulated aminopeptidase (IRAP)

    European Journal of Medicinal Chemistry Reports, Vol. 12

  2. Discovery of hybrid Glypromate conjugates with neuroprotective activity against paraquat-induced toxicity

    RSC Medicinal Chemistry, Vol. 15, Núm. 11, pp. 3711-3727

  3. Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents

    Biomedicine and Pharmacotherapy, Vol. 173

  4. Exploring structural determinants of neuroprotection bias on novel glypromate conjugates with bioactive amines

    European Journal of Medicinal Chemistry, Vol. 267

  5. Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy

    Pharmaceutics, Vol. 16, Núm. 1

  6. Multicomponent reactions driving the discovery and optimization of agents targeting central nervous system pathologies

    Beilstein Journal of Organic Chemistry, Vol. 20, pp. 3151-3173

  7. N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)

    Journal of Medicinal Chemistry, Vol. 67, Núm. 13, pp. 11003-11023

  8. Progress on the development of Class A GPCR-biased ligands

    British Journal of Pharmacology

  9. Telescoped One-Pot Strategy for the Assembly of cis-4-Hydroxy-l-Prolyl Amides

    ACS Sustainable Chemistry and Engineering, Vol. 12, Núm. 46, pp. 16986-16998

2023

  1. A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery

    Molecules, Vol. 28, Núm. 24

  2. Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences

    ACS Chemical Neuroscience, Vol. 14, Núm. 4, pp. 554-572

  3. Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques

    Journal of Medicinal Chemistry, Vol. 66, Núm. 6, pp. 3798-3817

  4. Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase

    Journal of Medicinal Chemistry, Vol. 66, Núm. 1, pp. 235-250

  5. Exploring the Effect of Halogenation in a Series of Potent and Selective A2BAdenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 66, Núm. 1, pp. 890-912

  6. Fluorescence based HTS-compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells

    Frontiers in Molecular Biosciences, Vol. 10

  7. Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  8. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)

    European Journal of Medicinal Chemistry, Vol. 248

  9. Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs

    Biomedicine and Pharmacotherapy, Vol. 164